Development and validation of liquid chromatography method for determination of Ibrutinib in finished dosage forms using quality by design approach-Reference-Cited by-同舟云学术

Development and validation of liquid chromatography method for determination of Ibrutinib in finished dosage forms using quality by design approach

Published:2022-03-31 Issue:7 Volume:5 Page:254-266
ISSN:2573-1815
Container-title:SEPARATION SCIENCE PLUS
language:en
Short-container-title:Separation Science Plus

Author:

Konduru Naresh¹²,Gundla Rambabu¹,Dongala Thirupathi¹³,Katari Naresh Kumar¹,Mallavarapu Ravindra¹

Affiliation:

1. Department of Chemistry School of Science GITAM (deemed to be) University Sangareddy India

2. Analytical Research and Development Yunnan Longjin Careyou Pharmaceutical Co., Ltd. Kunming city P. R. China

3. Analytical Research and Development Department Cambrex High point Inc. High Point North Carolina USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sscp.202100063

Reference21 articles.

1. Determination of potential genotoxic impurity hydrazine hydrate in Ibrutinib by RP‐liquid chromatography;Ramana Reddy G;Mater Today,2020

2. Development and validation of novel and highly sensitive stability‐indicating reverse phase ultra performance liquid chromatography method for quantification of Ibrutinib and its ten degradation products;Mehta L;J Pharm Sci.,2020

3. Development and Validation of a Stability-indicating Method for Ibrutinib: Identification and Separation of Degradation Products, Known and Genotoxic Impurities Using RP-HPLC/PDA and QDa Mass Detectors

4. Degradation studies of Ibrutinib under stress conditions: characterisation and structural elucidation of novel degradants;Soujanya V;J Pharm Biomed Anal.,2019

5. Development of a New RP‐HPLC method for the Estimation of Ibrutinib;Jagadeesh N;Sch Acad J Pharm.,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-vivo pharmacokinetic study of ibrutinib-loaded nanostructured lipid carriers in rat plasma by sensitive spectrofluorimetric method using harmonized approach of quality by design and white analytical chemistry;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-11

2. Development and Validation of a Simple HPLC–UV‐Based Bioanalytical Method for Estimation of Acalabrutinib in Rat Plasma and Its Application in Evaluation of Drug‐Loaded Nanocrystal Formulation;SEPARATION SCIENCE PLUS;2024-08-15

3. Comprehensive strategy of white analytical chemistry and analytical quality by design to sensitive spectrofluorimetric method for in-vitro drug release kinetic study of Ibrutinib-loaded nanostructured lipid carriers for leukemia via lymphatic targeting;Microchemical Journal;2024-03

4. Structural Elucidation of Novel Degradation Impurities of Ibrutinib in Ibrutinib Tablets Using Preparative Chromatography, LCMS, HRMS and 2D NMR Techniques;Journal of Chromatographic Science;2024-02-09

5. Development and validation of a stability‐indicating ultra‐high‐performance liquid chromatography method for the estimation of ibrutinib and trace‐level quantification of related substances using quality‐by‐design approach;Biomedical Chromatography;2023-12-11